Literature DB >> 23859166

Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer's disease.

M Kondo1, T Tokuda, M Itsukage, N Kuriyama, S Matsushima, K Yamada, H Nakanishi, M Ishikawa, M Nakagawa.   

Abstract

This study aimed to elucidate the incidence and distribution of the cortical retention of Pittsburgh compound B (PIB) in patients with idiopathic normal pressure hydrocephalus (iNPH) and clarify the differences from those in patients with Alzheimer's disease (AD). Ten patients with iNPH without any clinical signs indicative of AD were enrolled in this study. Cerebral retention of PIB in positron emission tomography (PET) in iNPH patients was compared with those in seven age-matched AD patients. The CSF levels of β-amyloid 1-42 peptide (Aβ42), which inversely decrease with cerebral amyloid burden, were also measured. Three of the ten patients with iNPH showed increased cortical PIB retention. Although the mean cortical SUV ratios were similar, the distribution of PIB retention differed widely between the patients with iNPH and AD. PIB retention was limited to the high-convexity parasagittal areas in iNPH patients, whereas it spread over the frontal and parietotemporal areas in AD. The coronal images of PIB-PET were more informative than conventional transverse images in evaluating the distribution pattern of cortical PIB retention. Two iNPH patients with higher cortical PIB retention had the lowest levels of CSF Aβ42, indicating that PIB retention in iNPH would not reflect a simple delay in PIB clearance but its binding to existing Aβ amyloid in the brain. Our results indicate that iNPH is one of the diseases exhibiting cortical PIB retention. The characteristic distribution of PIB retention in iNPH could be useful in the differential diagnosis between iNPH and AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23859166      PMCID: PMC5278862          DOI: 10.1177/197140091302600107

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  14 in total

1.  Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET.

Authors:  Bedda L Rosario; Lisa A Weissfeld; Charles M Laymon; Chester A Mathis; William E Klunk; Michael D Berginc; Jeffrey A James; Jessica A Hoge; Julie C Price
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

2.  Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting.

Authors:  R Bech-Azeddine; P Høgh; M Juhler; F Gjerris; G Waldemar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

3.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

Authors:  John R Cirrito; Kelvin A Yamada; Mary Beth Finn; Robert S Sloviter; Kelly R Bales; Patrick C May; Darryle D Schoepp; Steven M Paul; Steven Mennerick; David M Holtzman
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

4.  Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.

Authors:  Roy Hamilton; Sunil Patel; Edward B Lee; Eric M Jackson; Joanna Lopinto; Steven E Arnold; Christopher M Clark; Anuj Basil; Leslie M Shaw; Sharon X Xie; M Sean Grady; John Q Trojanowski
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

5.  Cortical brain biopsy in long-term prognostication of 468 patients with possible normal pressure hydrocephalus.

Authors:  Ville Leinonen; Anne M Koivisto; Irina Alafuzoff; Okko T Pyykkö; Jaana Rummukainen; Mikael von Und Zu Fraunberg; Juha E Jääskeläinen; Hilkka Soininen; Jaakko Rinne; Sakari Savolainen
Journal:  Neurodegener Dis       Date:  2012-02-10       Impact factor: 2.977

6.  Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response.

Authors:  J Golomb; J Wisoff; D C Miller; I Boksay; A Kluger; H Weiner; J Salton; W Graves
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

7.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

8.  Guidelines for management of idiopathic normal pressure hydrocephalus.

Authors:  Masatsune Ishikawa; Masaaki Hashimoto; Nobumasa Kuwana; Etsuro Mori; Hiroji Miyake; Akihiko Wachi; Totaro Takeuchi; Hiroaki Kazui; Hiroshi Koyama
Journal:  Neurol Med Chir (Tokyo)       Date:  2008       Impact factor: 1.742

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

View more
  4 in total

1.  Prognostic value of amyloid PET scan in normal pressure hydrocephalus.

Authors:  Hyemin Jang; Seong Beom Park; Yeshin Kim; Ko Woon Kim; Jung Il Lee; Sung Tae Kim; Kyung Han Lee; Eun-Suk Kang; Yeong Sim Choe; Sang Won Seo; Hee Jin Kim; Yeo Jin Kim; Cindy W Yoon; Duk L Na
Journal:  J Neurol       Date:  2017-11-11       Impact factor: 4.849

2.  Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease.

Authors:  Shize Li; Nini Wang; Jiyu Lou; Xiaoman Zhang
Journal:  Exp Ther Med       Date:  2015-03-27       Impact factor: 2.447

3.  Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.

Authors:  Harutsugu Tatebe; Takashi Kasai; Takuma Ohmichi; Yusuke Kishi; Tomoshi Kakeya; Masaaki Waragai; Masaki Kondo; David Allsop; Takahiko Tokuda
Journal:  Mol Neurodegener       Date:  2017-09-04       Impact factor: 14.195

4.  Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.

Authors:  Maria Vittoria Mattoli; Giorgio Treglia; Maria Lucia Calcagni; Annunziato Mangiola; Carmelo Anile; Gianluca Trevisi
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.